In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. [electronic resource]
- Journal of medicinal chemistry Jul 2009
- 4161-72 p. digital
Publication Type: Journal Article
1520-4804
10.1021/jm900302q doi
Animals Humans Inhibitory Concentration 50 Male Metabolic Clearance Rate Pyrazines--chemistry Rats Receptors, Corticotropin-Releasing Hormone--antagonists & inhibitors CRF Receptor, Type 1